Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Oct;19(4):623-9.
doi: 10.1111/j.1750-3639.2008.00206.x. Epub 2008 Aug 15.

Interphase cytogenetics for 1p19q and t(1;19)(q10;p10) may distinguish prognostically relevant subgroups in extraventricular neurocytoma

Affiliations

Interphase cytogenetics for 1p19q and t(1;19)(q10;p10) may distinguish prognostically relevant subgroups in extraventricular neurocytoma

Fausto J Rodriguez et al. Brain Pathol. 2009 Oct.

Abstract

Co-deletion of chromosome arms 1p and 19q, characteristic of oligodendroglial tumors, was recently found to be mediated by t(1;19)(q10;p10). To evaluate the prevalence of 1p19q co-deletion and t(1;19) in extraventricular neurocytomas (EVN), we studied tumors from 23 patients, including 13 females and 10 males (median age at diagnosis 34 years, range 2-76 years). Fluorescence in situ hybridization (FISH) studies were performed with probes targeting 1p36/1q25 and 19q13/19p13 to assess for 1p19q co-deletion, as well as chromosome 1 alpha-satellite and 19p12 to detect t(1;19)(q10;p10). FISH was successful in 21 (91%) cases and demonstrated 1p19q co-deletion in five cases (24%) or isolated 1p loss in two cases (10%). Evidence for t(1;19) was found in four (of five) cases with 1p19q co-deletion. Three tumors with 1p19q loss and t(1;19) demonstrated atypical histologic features, compared with one (of 17) tumors without 1p19q co-deletion (P = 0.01, Fisher exact test). In addition, tumors with t(1;19) showed increased mitotic activity compared with tumors without t(1;19) (P = 0.045; Wilcoxon rank sum test). The four patients with t(1;19) developed tumor recurrence (n = 3), or expired (n = 2) 3.5 to 5.5 years after first resection. These results suggest that 1p19q loss and t(1;19) occur in a subset of EVN, and may be associated with aggressive histology in these tumors.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Histologic features of extraventricular neurocytoma (Case 8). Morphologic features of neuronal differentiation were evident on hematoxylin–eosin stain (A,B), including extensive neuropil formation and neurocytic cytology. Immunohistochemical stains for synaptophysin labels individual cells and neuropil (C). Neu‐N stain was positive in a nuclear fashion in all cases tested (D). Electron microscopy demonstrating dense core secretory granules (E).
Figure 2
Figure 2
t(1;19) and 1p loss coexist in the same cells (Case 4). Three‐color fluorescence in situ hybridization strategy demonstrates a red/green fusion and a single aqua signal representing t(1;19) and 1p loss in the same cells, respectively (left). The same tumor also demonstrates a single red signal and two green signals in most cells reflecting 19q loss (right).
Figure 3
Figure 3
1p19q loss reflecting genetic heterogeneity (Case 1). The pattern of 1p19q loss in this case was unique, as it was limited to separate geographic areas (hematoxylin–eosin stain) (A). Dual‐color fluorescence in situ hybridization studies demonstrate a normal chromosome 1 (B) but 19q loss in most areas (C). Relative 1p loss with aneusomy (D) was a focal finding in an area showing no abnormalities in chromosome 19 (E). t(1;19) was absent (not shown).
Figure 4
Figure 4
Fluorescence in situ hybridization studies identify two distinct subgroups in EVN. Scatterplot demonstrates increased mitoses per 10 high‐power fields in extraventricular neurocytomas (EVN) with 1p19 co‐deletion and t(1;19) as compared with EVN without 1p19q loss and t(1;19) (P = 0.045, Wilcoxon rank sum test).

References

    1. Brat DJ, Scheithauer BW, Eberhart CG, Burger PC (2001) Extraventricular neurocytomas: pathologic features and clinical outcome. Am J Surg Pathol 25:1252–1260. - PubMed
    1. Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR et al (1998) Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 90:1473–1479. - PubMed
    1. Cairncross G, Berkey B, Shaw E, Jenkins R, Scheithauer B, Brachman D et al (2006) Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402. J Clin Oncol 24:2707–2714. - PubMed
    1. Ducray F, Idbaih A, Reynies A, Bieche I, Thillet J, Mokhtari K et al (2008) Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile. Mol Cancer 7:41. - PMC - PubMed
    1. Figarella‐Branger D, Soylemezoglu F, Burger P (2007) Central neurocytoma and extraventricular neurocytoma. In: Who Classification of Tumours of the Central Nervous System, Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds), pp. 106–109. International Agency For Research On Cancer: Lyon, France.

Publication types

MeSH terms